This Week in Health CareSM, January 11, 2017
Every Wednesday, Stateside Associates selects some health care-related state and local events to highlight in This Week in Health Care.
To provide feedback, or for more information about these issues or Stateside Associates’ Health Care Practice, please contact Robert Holden at (703) 525-7466 or firstname.lastname@example.org.
There are no Groups events to report.
The House Health Committee will hold a public hearing January 12 regarding H.B. 2032, which requires a pharmacist, intern or pharmacy technician, within ten days after a change in that person’s employer, employer’s address, or contact information, to electronically update the person’s online Board of Pharmacy profile or give written notice to Board office staff of the new information. In addition, the measure requires a licensee to provide written notice to Board office staff of a change in the licensee’s residency status as authorized by the United States Citizenship and Immigration Services. Zack Cairns at email@example.com
The Telehealth Advisory Council will meet January 17 to discuss recommendations to increase the use and accessibility of services provided by telehealth. Becky Lukaesko at firstname.lastname@example.org
The Department of Health and Family Services will accept comments until January 12 regarding proposed amendments to medical payment rules. Chris Johnson at email@example.com
The House Human Services Committee will hold a public hearing January 13 regarding H.B. 142, which requires insurers to cover mental illness and substance use disorders at a level of benefits no less favorable than that provided for physical illness generally. Arielle Woodmore at firstname.lastname@example.org
The House Human Services Committee will hold a public hearing January 16 regarding H.B. 195, which requires a pharmacist to notify a patient that a generic drug is rated less than A or AB on the United States Food and Drug Administration’s list of approved drugs with therapeutic equivalence evaluations whenever a prescriber writes a prescription for a generic drug with that rating. Arielle Woodmore at email@example.com
The House Health, Human Services and Elderly Affairs Committee will hold a public hearing January 17 regarding H.B. 200, which allows licensed residential care facilities, licensed health facilities and licensed physicians to dispense medication and use equipment and therapies which are not approved by the United States Food and Drug Administration. Allison Rollins at firstname.lastname@example.org
The Assembly Law and Public Safety Committee will hold a public hearing January 12 regarding A.B. 4219, which establishes 14 as the age in which a person can make an anatomical gift. In addition, this measure also allows the New Jersey Motor Vehicle Commission to provide people as young as 14 with the necessary documents to register as an organ donor. Allison Rollins at email@example.com
The Agency of Human Services will accept comments until January 16 regarding proposed amendments updating the authority, process and enforcement for annual fees collections imposed on pharmaceutical manufacturers. Chris Johnson at firstname.lastname@example.org
The Senate Health Care Committee will meet for an educational work session January 12 to discuss prescription drug pricing. Zack Cairns at email@example.com
The Pharmacy Examining Board will hold a public hearing January 17 regarding proposed amendments to the rule chapter concerning sterile pharmaceuticals to repeal the rules and replace them with rules concerning sterile compounding and non-sterile compounding. Becky Lukaesko at firstname.lastname@example.org